NO20024331L - Behandling av lidelser relatert til det serotonerge system - Google Patents

Behandling av lidelser relatert til det serotonerge system

Info

Publication number
NO20024331L
NO20024331L NO20024331A NO20024331A NO20024331L NO 20024331 L NO20024331 L NO 20024331L NO 20024331 A NO20024331 A NO 20024331A NO 20024331 A NO20024331 A NO 20024331A NO 20024331 L NO20024331 L NO 20024331L
Authority
NO
Norway
Prior art keywords
treatment
disorders related
serotonergic system
serotonergic
deramsiclan
Prior art date
Application number
NO20024331A
Other languages
English (en)
Other versions
NO20024331D0 (no
Inventor
Harri Kanerva
Outi Maeki-Ikola
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20024331L publication Critical patent/NO20024331L/no
Publication of NO20024331D0 publication Critical patent/NO20024331D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Den foreliggende oppfinnelse angår deramsiklan,. (lR,2S,4R)-(-)-2-[N,N-(dimetylaminoetoksy)]-2-fenyl-l,7,7-trimetyl-bisyklo[2.2.ljheptan, og dens anvendelse til behandling av lidelser relatert til det serotonerge system hos mennesker, spesifikt depresjon og engstelse.
NO20024331A 2000-03-17 2002-09-10 Behandling av lidelser relatert til det serotonerge system NO20024331D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00302207A EP1133986A1 (en) 2000-03-17 2000-03-17 Use of deramciclane for the treatment of anxiety and depression
PCT/FI2001/000266 WO2001068067A2 (en) 2000-03-17 2001-03-16 Use of deramciclane for the treatment of anxiety and depression

Publications (2)

Publication Number Publication Date
NO20024331L true NO20024331L (no) 2002-09-10
NO20024331D0 NO20024331D0 (no) 2002-09-10

Family

ID=8172804

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024331A NO20024331D0 (no) 2000-03-17 2002-09-10 Behandling av lidelser relatert til det serotonerge system

Country Status (19)

Country Link
EP (2) EP1133986A1 (no)
JP (1) JP2004500394A (no)
KR (1) KR20020089399A (no)
CN (1) CN1418094A (no)
AR (1) AR028260A1 (no)
AU (2) AU2001248383A1 (no)
BG (1) BG107196A (no)
BR (1) BR0109172A (no)
CA (1) CA2403350A1 (no)
CZ (1) CZ20023025A3 (no)
EA (1) EA200200987A1 (no)
HU (1) HUP0204528A3 (no)
IL (1) IL151493A0 (no)
MX (1) MXPA02008998A (no)
NO (1) NO20024331D0 (no)
PL (1) PL359288A1 (no)
SK (1) SK12982002A3 (no)
WO (1) WO2001068067A2 (no)
ZA (1) ZA200207111B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002612A0 (fi) * 2000-11-28 2000-11-28 Orion Yhtymae Oyj Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi
CN105497021A (zh) * 2014-09-25 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物治疗焦虑障碍的医药用途
CN105497020A (zh) * 2014-09-25 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物的光学异构体治疗疼痛的医药用途
CN109758452A (zh) * 2014-09-25 2019-05-17 石药集团中奇制药技术（石家庄）有限公司 胺类化合物治疗疼痛的医药用途
CN109758454A (zh) * 2014-09-25 2019-05-17 石药集团中奇制药技术（石家庄）有限公司 胺类化合物的光学异构体治疗焦虑障碍的医药用途

Also Published As

Publication number Publication date
HUP0204528A3 (en) 2004-08-30
BR0109172A (pt) 2002-11-26
MXPA02008998A (es) 2003-04-25
WO2001068067A3 (en) 2002-07-11
CZ20023025A3 (cs) 2003-05-14
WO2001068067A2 (en) 2001-09-20
CN1418094A (zh) 2003-05-14
ZA200207111B (en) 2003-12-04
AU2001248383A1 (en) 2002-07-16
SK12982002A3 (sk) 2003-05-02
EP1133986A1 (en) 2001-09-19
KR20020089399A (ko) 2002-11-29
AU4838301A (en) 2001-09-24
PL359288A1 (en) 2004-08-23
IL151493A0 (en) 2003-04-10
HUP0204528A2 (en) 2003-05-28
AR028260A1 (es) 2003-04-30
JP2004500394A (ja) 2004-01-08
EP1263424A2 (en) 2002-12-11
BG107196A (bg) 2003-02-28
CA2403350A1 (en) 2001-09-20
EA200200987A1 (ru) 2003-04-24
NO20024331D0 (no) 2002-09-10

Similar Documents

Publication Publication Date Title
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
NO20014303D0 (no) JAK-3-inhibitorer for behandling av allergiske lidelser
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
ATE284690T1 (de) Antithrombotische diamine
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
SE9603669D0 (sv) New combination
SI1546127T1 (sl) Novi pirimidinamidni derivati in njihova uporaba
DK1339406T3 (da) Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet
GB0111186D0 (en) Novel compounds
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
MY124786A (en) Bis-arylsulfones
DK1343472T3 (da) Thixotropisk næsespray
DK1274414T3 (da) Nasal administration af Metocloropramid til behandling af Gastroparese
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
WO2001068067A3 (en) Use of deramciclane for the treatment of anxiety and depression
NO20032091L (no) Blandinger av N-(metyletylaminokarbonyl)-4-(3- metylfenylamino)-3-pyridylsulfonamid og sykliske oligosakkarider
NO20052999L (no) Ny synergistisk kombinasjon omfattende roflumilast og formoterol
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
HRPK20040328B3 (en) Pharmaceutical composition comprising gamma-butyrobetaine
DE60122764D1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
ATE528000T1 (de) Verfahren und zubereitungen zur behandlung des alkoholismus und der alkoholabhängigkeit

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application